Required citation and footnote for the 4-item or 8-item MMAS

MMAS-4

Morisky DE, Green LW, Levine DM. Concurrent and Predictive Validity of a Self-Reported Measure of Medication Adherence and Long-Term Predictive Validity of Blood Pressure Control.  Medical Care 1986

Morisky DE, Malotte CK, Choi P, et al. A Patient Education Program to Improve Adherence Rate with Anti-tuberculosis Drug Regimens.  Health Education Quarterly 1990; 17:253-286

Morisky DE, DiMatteo MR, Improving the measurement of self-reported medication non-adherence: Final response. J Clin Epidemio 2011; 64:258-263

MMAS-8

Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication Adherence Measure for Hypertension Control. Journal of Clinical Hypertension 2008; 10(5):348-354

Berlowitz DR, Foy CG, Kazis LE, Bolin L, Conroy LB, Fitzpatrick P, Gure TR, Kimmel PL, Kirscner K, Morisky DE, Newman J, Okney C, Oparil S, et al. for the SPRINT Study Research Group. Impact of Intensive Blood Pressure Therapy on Patient-Reported Outcomes: Outcomes Results from the SPRINT Study. N Engl J Med. 2017;377:733-44.

​Bress AP, Bellows BK, King J, Hess  R, Beddhu S, Zhang Z, Berlowitz DR, Conroy MB, Fine L, Oparil S,  Morisky DE, Kazis LE, Ruiz-Negron N, Powell J, Tamariz L, Whittle J, et al, for the SPRINT Research Group and the SPRINT Economics and Health Related Quality of Life Subcommittee. Cost-Effectiveness of Intensive versus Standard Blood Pressure Control.  N Engl J Med 2017;377:745-55. DOI: 10.1056/NEJMsa1616035